1-1 of 1
Keywords: Unfit
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Dose Reduced Induction Therapy (A)-AIDA in Patients with Acute Myeloid Leukemia, Being Unfit for Standard 7+3 Chemotherapy and Literature Review of Acute Myeloid Leukemia Treatment in Unfit/Older AML Patients

Available to Purchase
Subject Area:
Hematology , Oncology
Karin Mayer, Leonie Birk, Katjana Schwab, Ingo G.H. Schmidt-Wolf, Marie von Lilienfeld-Toal, Peter Brossart, Axel Glasmacher, Corinna Hahn-Ast
Journal: Acta Haematologica
Acta Haematol (2025)
https://doi.org/10.1159/000545792
Published Online: 05 May 2025
... to in the content or advertisements. 2025 Acute myeloid leukemia Unfit Frail patients Induction chemotherapy Complete remission Hypomethylating agents Venetoclax Acute myeloid leukemia (AML) represents the second most commonly diagnosed form of leukemia in adults. The incidence of AML...
View article titled, Dose Reduced Induction Therapy (A)-AIDA in Patients with Acute Myeloid Leukemia, Being Unfit for Standard 7+3 Chemotherapy and Literature Review of Acute Myeloid Leukemia Treatment in Unfit/Older AML Patients
Open the PDF for Dose Reduced Induction Therapy (A)-AIDA in Patients with Acute Myeloid Leukemia, Being Unfit for Standard 7+3 Chemotherapy and Literature Review of Acute Myeloid Leukemia Treatment in Unfit/Older AML Patients in another window